基本信息
浏览量:115
职业迁徙
个人简介
Nano Main Field:
Via a nanotechnology platform, we search for small molecule drugs, which are designed to neutralize, inhibit, or target new and novel factors expressed on cancer cells. We base our proteomic analyses on drug design in collaboration with several in-house and outside groups to develop new targeted therapies for cancer.
Research Interests
The aims of my research program are to study tumor cell biology and growth in the context of angiogenesis, tumor invasion and metastasis, tumor microenvironment, and cancer stem cells (CSCs), and to identify new targets that will react to targeted therapies using innovative and nanotechnology approaches. A major focus of my laboratory is the exploration of angiogenesis and metastasis associated with circulating bone marrow derived cells (BMDCs), and the impact of several types of chemotherapy or other treatment regimens on metastasis growth. In addition, we investigate the effects of newly developed targeted anti-cancer drugs on tumor cell growth especially BMDC mobilization and colonization of tumors, metastasis spread, and CSCs expansion. We also study the impact of host bone marrow responses on tumor growth after various drug treatments and/or other treatment regimens and seek alternative and innovative approaches to improve treatment outcome.
Via a nanotechnology platform, we search for small molecule drugs, which are designed to neutralize, inhibit, or target new and novel factors expressed on cancer cells. We base our proteomic analyses on drug design in collaboration with several in-house and outside groups to develop new targeted therapies for cancer.
Research Interests
The aims of my research program are to study tumor cell biology and growth in the context of angiogenesis, tumor invasion and metastasis, tumor microenvironment, and cancer stem cells (CSCs), and to identify new targets that will react to targeted therapies using innovative and nanotechnology approaches. A major focus of my laboratory is the exploration of angiogenesis and metastasis associated with circulating bone marrow derived cells (BMDCs), and the impact of several types of chemotherapy or other treatment regimens on metastasis growth. In addition, we investigate the effects of newly developed targeted anti-cancer drugs on tumor cell growth especially BMDC mobilization and colonization of tumors, metastasis spread, and CSCs expansion. We also study the impact of host bone marrow responses on tumor growth after various drug treatments and/or other treatment regimens and seek alternative and innovative approaches to improve treatment outcome.
研究兴趣
论文共 225 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer discoveryno. 8 (2024): 1375-1388
Madeleine Benguigui,Tim J. Cooper,Prajakta Kalkar,Sagie Schif-Zuck,Ruth Halaban,Antonella Bacchiocchi,Iris Kamer,Abhilash Deo,Bar Manobla,Rotem Menachem,Jozafina Haj-Shomaly,Avital Vorontsova,Ziv Raviv,Chen Buxbaum,Petros Christopoulos,Jair Bar,Michal Lotem,Mario Sznol,Amiram Ariel,Shai S. Shen-Orr,Yuval Shaked
CANCER CELLno. 2 (2024)
Jair Bar,Raya Leibowitz,Niels Reinmuth, Astrid Ammendola,Eyal Jacob,Mor Moskovitz,Adva Levy-Barda,Michal Lotem,Rivka Katsenelson,Abed Agbarya,Mahmoud Abu-Amna,Maya Gottfried,Tatiana Harkovsky,Ido Wolf,Ella Tepper, Gil Loewenthal,Ben Yellin, Yehuda Brody,Nili Dahan, Maya Yanko,Coren Lahav,Michal Harel, Shani Raveh Shoval,Yehonatan Elon,Itamar Sela,Adam P. Dicker,Yuval Shaked
Frontiers in immunology (2024): 1364473-1364473
Frontiers research topics (2023)
Clinical & experimental metastasis (2023)
openalex(2023)
crossref(2023)
Dror Alishekevitz,Rotem Bril,David Loven,Valeria Miller,Tali Voloshin, Svetlana Gingis-Velistki,Ella Fremder,Stefan J. Scherer,Yuval Shaked
crossref(2023)
加载更多
作者统计
#Papers: 224
#Citation: 10742
H-Index: 54
G-Index: 100
Sociability: 7
Diversity: 0
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn